| Pos |
No. |
Sex |
Age |
Organ |
Pathology diagnosis |
Stage |
TNM |
Type † |
|
A1 |
1 |
F |
47 |
Uterus |
Leiomyoma |
– |
– |
Benign |
|
A2 |
2 |
F |
49 |
Uterus |
Leiomyoma |
– |
– |
Benign |
|
A3 |
3 |
F |
50 |
Uterus |
Leiomyoma |
– |
– |
Benign |
|
A4 |
4 |
F |
41 |
Uterus |
Leiomyoma |
– |
– |
Benign |
|
A5 |
5 |
F |
32 |
Uterus |
Leiomyoma |
– |
– |
Benign |
|
A6 |
6 |
F |
43 |
Uterus |
Leiomyoma |
– |
– |
Benign |
|
A7 |
7 |
F |
53 |
Uterus |
Leiomyoma |
– |
– |
Benign |
|
A8 |
8 |
F |
50 |
Uterus |
Leiomyoma |
– |
– |
Benign |
|
A9 |
9 |
F |
45 |
Uterus |
Leiomyoma |
– |
– |
Benign |
|
A10 |
10 |
F |
45 |
Uterus |
Leiomyoma |
– |
– |
Benign |
|
B1 |
11 |
F |
48 |
Uterus |
Leiomyoma |
– |
– |
Benign |
|
B2 |
12 |
F |
39 |
Uterus |
Leiomyoma |
– |
– |
Benign |
|
B3 |
13 |
F |
54 |
Uterus |
Leiomyoma |
– |
– |
Benign |
|
B4 |
14 |
F |
50 |
Uterus |
Leiomyoma |
– |
– |
Benign |
|
B5 |
15 |
F |
49 |
Uterus |
Leiomyoma |
– |
– |
Benign |
|
B6 |
16 |
F |
46 |
Uterus |
Leiomyoma |
– |
– |
Benign |
|
B7 |
17 |
F |
37 |
Uterus |
Leiomyoma |
– |
– |
Benign |
|
B8 |
18 |
F |
66 |
Uterus |
Leiomyoma |
– |
– |
Benign |
|
B9 |
19 |
F |
34 |
Uterus |
Leiomyoma |
– |
– |
Benign |
|
B10 |
20 |
F |
43 |
Uterus |
Leiomyoma |
– |
– |
Benign |
|
C1 |
21 |
F |
41 |
Abdominal cavity |
Leiomyoma |
– |
– |
Benign |
|
C2 |
22 |
F |
38 |
Retroperitoneum |
Leiomyoma |
– |
– |
Benign |
|
C3 |
23 |
F |
49 |
Retroperitoneum |
Leiomyoma |
– |
– |
Benign |
|
C4 |
24 |
F |
49 |
Esophagus |
Leiomyoma |
– |
– |
Benign |
|
C5 |
25 |
M |
44 |
Esophagus |
Leiomyoma |
– |
– |
Benign |
|
C6 |
26 |
F |
51 |
Abdominal cavity |
Low grade leiomyosarcoma |
IA |
T1aN0M0 |
Malignant |
|
C7 |
27 |
M |
72 |
Abdominal cavity |
Low grade leiomyosarcoma |
IB |
T2bN0M0 |
Malignant |
|
C8 |
28 |
M |
45 |
Abdominal cavity |
Low grade leiomyosarcoma |
IB |
T2bN0M0 |
Malignant |
|
C9 |
29 |
M |
37 |
Mediastinum |
Low grade leiomyosarcoma |
IB |
T2bN0M0 |
Malignant |
|
C10 |
30 |
F |
63 |
Mesentery |
Low grade leiomyosarcoma |
IB |
T2bN0M0 |
Malignant |
|
D1 |
31 |
F |
35 |
Uterus |
Low grade leiomyosarcoma |
IB |
T2N0M0 |
Malignant |
|
D2 |
32 |
F |
35 |
Uterus |
Low grade leiomyosarcoma |
IB |
T2N0M0 |
Malignant |
|
D3 |
33 |
F |
76 |
Mesentery |
Low-intermediate grade leiomyosarcoma |
IIB |
T2bN0M0 |
Malignant |
|
D4 |
34 |
M |
52 |
Abdominal cavity |
Intermediate grade leiomyosarcoma |
IIB |
T2bN0M0 |
Malignant |
|
D5 |
35 |
M |
80 |
Epiploon |
Intermediate grade leiomyosarcoma |
IIB |
T2bN0M0 |
Malignant |
|
D6 |
36 |
F |
40 |
Uterus |
Pleomorphic intermediate grade leiomyosarcoma |
IIB |
T2N0M0 |
Malignant |
|
D7 |
37 |
F |
33 |
Uterus |
Intermediate grade leiomyosarcoma |
IIA |
T1bN0M0 |
Malignant |
|
D8 |
38 |
F |
62 |
Uterus |
Intermediate grade leiomyosarcoma |
IIB |
T2N0M0 |
Malignant |
|
D9 |
39 |
M |
65 |
Mesentery |
Intermediate grade leiomyosarcoma |
IIA |
T1bN0M0 |
Malignant |
|
D10 |
40 |
F |
59 |
Abdominal cavity |
Intermediate grade leiomyosarcoma |
IIA |
T1bN0M0 |
Malignant |
|
E1 |
41 |
F |
47 |
Uterus |
Intermediate grade leiomyosarcoma |
IIA |
T1bN0M0 |
Malignant |
|
E2 |
42 |
F |
38 |
Uterus |
Intermediate grade leiomyosarcoma |
IIB |
T2N0M0 |
Malignant |
|
E3 |
43 |
F |
40 |
Uterus |
High grade leiomyosarcoma |
IIIB |
T2N0M0 |
Malignant |
|
E4 |
44 |
F |
63 |
Uterus |
High grade leiomyosarcoma |
IIB |
T2N0M0 |
Malignant |
|
E5 |
45 |
F |
57 |
Uterus |
Pleomorphic high grade leiomyosarcoma |
IIIB |
T2N0M0 |
Malignant |
|
E6 |
46 |
F |
52 |
Abdominal cavity |
Pleomorphic high grade leiomyosarcoma |
IIIB |
T2bN0M0 |
Malignant |
|
E7 |
47 |
F |
60 |
Mesentery |
High grade leiomyosarcoma with necrosis (sparse) |
IIIB |
T2bN0M0 |
Malignant |
|
E8 |
48 |
F |
58 |
Abdominal cavity |
High grade leiomyosarcoma |
IIIB |
T2bN0M0 |
Malignant |
|
E9 |
49 |
F |
46 |
Epiploon |
High grade leiomyosarcoma |
IIIB |
T2bN0M0 |
Malignant |
|
E10 |
50 |
M |
60 |
Abdominal cavity |
High grade leiomyosarcoma |
IIIB |
T2bN0M0 |
Malignant |
|
F1 |
51 |
M |
38 |
Back |
Intermediate grade epithelioid leiomyosarcoma |
IIA |
T1aN0M0 |
Malignant |
|
F2 |
52 |
F |
45 |
Uterus |
High grade epithelioid leiomyosarcoma (sparse) |
IIB |
T2N0M0 |
Malignant |
|
F3 |
53 |
F |
54 |
Pelvic cavity |
High grade epithelioid leiomyosarcoma |
IIB |
T2N0M0 |
Malignant |
|
F4 |
54 |
F |
13 |
Retroperitoneum |
Spindle cell rhabdomyosarcoma |
IIB |
T2N0M0 |
Malignant |
|
F5 |
55 |
F |
48 |
Retroperitoneum |
Spindle cell rhabdomyosarcoma |
IIB |
T2N0M0 |
Malignant |
|
F6 |
56 |
F |
50 |
Retroperitoneum |
Spindle cell rhabdomyosarcoma (sparse) |
IIB |
T2N0M0 |
Malignant |
|
F7 |
57 |
M |
44 |
Testis |
Spindle cell rhabdomyosarcoma |
IIIB |
T2bN0M0 |
Malignant |
|
F8 |
58 |
M |
49 |
Testis |
Spindle cell rhabdomyosarcoma |
IIB |
T2N0M0 |
Malignant |
|
F9 |
59 |
M |
15 |
Anus |
Aciniform rhabdomyosarcoma |
IIIB |
T2N0M0 |
Malignant |
|
F10 |
60 |
M |
18 |
Tongue |
Aciniform rhabdomyosarcoma |
IIIA |
T1bN0M0 |
Malignant |
|
G1 |
61 |
F |
23 |
Abdominal cavity |
Embryonal rhabdomyosarcoma |
IIIB |
T2bN0M0 |
Malignant |
|
G2 |
62 |
F |
40 |
Abdominal cavity |
Embryonal rhabdomyosarcoma |
IIIB |
T2bN0M0 |
Malignant |
|
G3 |
63 |
M |
21 |
Retroperitoneum |
Embryonal rhabdomyosarcoma |
IIIA |
T1N0M0 |
Malignant |
|
G4 |
64 |
M |
34 |
Testis |
Pleomorphic rhabdomyosarcoma |
IIIA |
T1bN0M0 |
Malignant |
|
G5 |
65 |
M |
42 |
Testis |
Pleomorphic rhabdomyosarcoma |
IIIB |
T2bN0M0 |
Malignant |
|
G6 |
66 |
F |
51 |
Uterine cervix |
Pleomorphic rhabdomyosarcoma |
IIIB |
T2bN0M0 |
Malignant |
|
G7 |
67 |
F |
32 |
Uterine cervix |
Pleomorphic rhabdomyosarcoma |
IIIB |
T2bN0M0 |
Malignant |
|
G8 |
68 |
F |
67 |
Uterine cervix |
Pleomorphic rhabdomyosarcoma |
IIIB |
T2bN0M0 |
Malignant |
|
G9 |
69 |
M |
15 |
Pleura |
Spindle cell rhabdomyosarcoma |
IIB |
T2bN0M0 |
Malignant |
|
G10 |
70 |
M |
35 |
Pleura |
Proliferative myositis (sparse) |
– |
– |
Inflammation |
|
H1 |
71 |
F |
56 |
Esophagus |
Cancer adjacent normal smooth muscle tissue |
– |
– |
NAT |
|
H2 |
72 |
F |
78 |
Uterus |
Cancer adjacent normal smooth muscle tissue and sparse gland |
– |
– |
NAT |
|
H3 |
73 |
M |
47 |
Stomach |
Cancer adjacent normal smooth muscle tissue (sparse) |
– |
– |
NAT |
|
H4 |
74 |
F |
53 |
Uterine cervix |
Cancer adjacent normal smooth muscle tissue |
– |
– |
NAT |
|
H5 |
75 |
M |
75 |
Soft tissue |
Cancer adjacent normal skeletal muscle tissue of right thigh |
– |
– |
NAT |
|
H6 |
76 |
F |
15 |
Soft tissue |
Normal skeletal muscle tissue of pectoralis major |
– |
– |
Normal |
|
H7 |
77 |
M |
25 |
Soft tissue |
Normal skeletal muscle tissue |
– |
– |
Normal |
|
H8 |
78 |
M |
16 |
Soft tissue |
Normal skeletal muscle tissue of neck |
– |
– |
Normal |
|
H9 |
79 |
M |
43 |
Soft tissue |
Normal skeletal muscle tissue |
– |
– |
Normal |
|
H10 |
80 |
M |
50 |
Soft tissue |
Normal skeletal muscle tissue of abdominal muscle |
– |
– |
Normal |
|
–
|
– |
M |
58 |
Skin |
Malignant melanoma (tissue marker) |
|
|
Malignant |
† For precise diagnosis, refer to pathology description.
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum